MedPath

Osteosarcopenia and Exercise

Not Applicable
Completed
Conditions
Osteoporosis, Osteopenia
Sarcopenia
Interventions
Other: exercise
Registration Number
NCT04526327
Lead Sponsor
Sisli Hamidiye Etfal Training and Research Hospital
Brief Summary

The purpose of this study is to assess the efficacy of combination of aerobic and resistive exercise on activities of daily living and risk of fall in osteosarcopenic patients

Detailed Description

After being informed about the study and potential risk, all patients giving written informed consent will undergo study entry.

to begin with: assessment with bioelectrical body composition analyzer and first exercise and assessment clinical scales

1th month: assessment with bioelectrical body composition analyzer and assessment clinical scales 3th month: assessment with bioelectrical body composition analyzer and assessment clinical scales

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
27
Inclusion Criteria
  • Over 70 years of age
  • Clinical diagnosis of osteoporosis or osteopenia
  • Independent mobilization
  • Walking speed < 0.8 m / sec
  • Grip strength < 20 kg for women, < 30 kg for men
Exclusion Criteria
  • Uncontrolled hypertension (systolic blood pressure> 200 mmHg, diastolic blood pressure> 110 mmHg)
  • Uncontrolled diabetes mellitus
  • Stroke, hip fracture, knee and hip arthroplasty, spinal surgery in the last 6 months
  • Severe cardiac arrhythmia
  • Myocardial infarction in the last 6 months
  • Severe dementia and difficulties in cooperation
  • Cardiac pacemaker
  • Dialysis
  • Acute infection
  • Severe edema
  • Malignancy patients
  • Severe anemia (Hgb <8 mg / dl)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
exercise groupexerciseFemale and male patients over 70 years of age with osteoporosis and sarcopenia
Primary Outcome Measures
NameTimeMethod
Change from Baseline on Skeletal Muscle Mass Measurement at month 1Baseline and Month 1

Assessment with bioelectrical body composition analyzer male: SMI\<9,2 kg/m2 female: SMI\<7,4 kg/m2

Change from Baseline on Timed Up and Go Test at month 3Baseline and Month 3

Stand up and walk 3 meters, turn around, walks back to the chair and sit down.14 seconds or longer : high risk for falling

Change from Baseline on Short Physical Performance Battery at month 1Baseline and Month 1

0-low perfomance, 12-good performance

Change from Baseline on Katz Activities of Daily Living Scale at month 1Baseline and Month 1

minimum 0, maximum 6, high scores: better

Change from Baseline on Katz Activities of Daily Living Scale at month 3Baseline and Month 3

minimum 0, maximum 6, high scores: better

Change from Baseline on Berg Balance Test at month 1Baseline and Month 1

maximum 56 point, a score of \< 45 indicates individuals may be at greater risk of falling.

Change from Baseline on Timed Up and Go Test at month 1Baseline and Month 1

Stand up and walk 3 meters, turn around, walks back to the chair and sit down.14 seconds or longer : high risk for falling

Change from Baseline on Five Times Sit to Stand Test at month 1Baseline and Month 1

Lower times: better scores

Change from Baseline on Berg Balance Test at month 3Baseline and Month 3

maximum 56 point, a score of \< 45 indicates individuals may be at greater risk of falling.

Change from Baseline on Skeletal Muscle Mass Measurement at month 3Baseline and Month 3

Assessment with bioelectrical body composition analyzer male: SMI\<9,2 kg/m2 female: SMI\<7,4 kg/m2

Change from Baseline on Short Physical Performance Battery at month 3Baseline and Month 3

0-low perfomance, 12-good performance

Change from Baseline on Five Times Sit to Stand Test at month 3Baseline and Month 3

Lower times: better scores

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Şişli Hamidiye Etfal Training and Research Hospital

🇹🇷

Istanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath